Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Inga Hansen

Showing results (51-60 of 56) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 56 results.
Journal of Experimental & Clinical Cancer Research : CR|July 12, 2025
In-depth assessment of BRAF, NRAS, KRAS, EGFR, and PIK3CA mutations on cell-free DNA in the blood of melanoma patients receiving immune checkpoint inhibitionIsabel Heidrich, Charlotte Rautmann, Cedric Ly, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|March 11, 2024
C-reactive protein flare predicts response to checkpoint inhibitor treatment in melanomaJulian Kött, Noah Zimmermann, Tim Zell, et al.
Acta Dermato-Venereologica|March 13, 2025
Patient Needs and Treatment Goals in Chronic Atopic Pruritus: Does Eczema Make a Difference?Svenja Müller, Claudia Zeidler, Christian Mess, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|October 3, 2024
Pegylated interferon-α2a in cutaneous T-cell lymphoma - a multicenter retrospective data analysis with 70 patientsInga Hansen-Abeck, Glenn Geidel, Finn Abeck, et al.
Journal for Immunotherapy of Cancer|March 5, 2026
Resistance to anti-PD-1 immunotherapy for stage III and IV melanoma: a global chart review studyElizabeth M Gaughan, Miso Kim, Ignacio Mendez, et al.
European Journal of Cancer (Oxford, England : 1990)|December 6, 2024
Improved survival of advanced melanoma patients receiving immunotherapy with concomitant antithrombotic therapy - A multicenter study on 2419 patients from the prospective skin cancer registry ADORegJulian Kött, Tim Zell, Noah Zimmermann, et al.
Pageof 6

Showing results (51-60 of 56) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 56 results.
Journal of Experimental & Clinical Cancer Research : CR|July 12, 2025
In-depth assessment of BRAF, NRAS, KRAS, EGFR, and PIK3CA mutations on cell-free DNA in the blood of melanoma patients receiving immune checkpoint inhibitionIsabel Heidrich, Charlotte Rautmann, Cedric Ly, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|March 11, 2024
C-reactive protein flare predicts response to checkpoint inhibitor treatment in melanomaJulian Kött, Noah Zimmermann, Tim Zell, et al.
Acta Dermato-Venereologica|March 13, 2025
Patient Needs and Treatment Goals in Chronic Atopic Pruritus: Does Eczema Make a Difference?Svenja Müller, Claudia Zeidler, Christian Mess, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|October 3, 2024
Pegylated interferon-α2a in cutaneous T-cell lymphoma - a multicenter retrospective data analysis with 70 patientsInga Hansen-Abeck, Glenn Geidel, Finn Abeck, et al.
Journal for Immunotherapy of Cancer|March 5, 2026
Resistance to anti-PD-1 immunotherapy for stage III and IV melanoma: a global chart review studyElizabeth M Gaughan, Miso Kim, Ignacio Mendez, et al.
European Journal of Cancer (Oxford, England : 1990)|December 6, 2024
Improved survival of advanced melanoma patients receiving immunotherapy with concomitant antithrombotic therapy - A multicenter study on 2419 patients from the prospective skin cancer registry ADORegJulian Kött, Tim Zell, Noah Zimmermann, et al.
Pageof 6